<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nine severely ill patients with a confirmed diagnosis of systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> were treated with recombinant gamma-interferon (gamma-IFN) in addition to the therapy they were previously receiving for their disease </plain></SENT>
<SENT sid="1" pm="."><plain>Improvements in clinical symptoms were noted in 7 of the patients, and median laboratory values also showed a marked improvement after gamma-IFN treatment </plain></SENT>
<SENT sid="2" pm="."><plain>A relapse occurred in 1 patient </plain></SENT>
<SENT sid="3" pm="."><plain>The results of this study should stimulate further research on the use of gamma-IFN in systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo>, particularly in determining the appropriate effective dosage </plain></SENT>
</text></document>